Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Unlock Free Earnings Estimates
Immuno-Biological Laboratories: Financial results presentation materials for the second quarter (interim period) for the fiscal year ending March 31, 2025 (43rd period)
Nov 28, 2024 14:30
Immuno-Biological Laboratories: Confirmation letter
Nov 14, 2024 08:04
Immuno-Biological Laboratories: Half Year Report - Term 43 (2024/04/01 - 2025/03/31)
Nov 14, 2024 08:02
Immuno-Biological Laboratories: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)
Nov 11, 2024 14:30
Read more